Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Vasopressin Antagonists in Polycystic Kidney Disease
Vicente E. Torres
Nephrology and Hypertension
Research output
:
Contribution to journal
›
Article
›
peer-review
39
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Vasopressin Antagonists in Polycystic Kidney Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Antidiuretic Hormone Receptor Antagonists
100%
Vasopressin Receptors
91%
Polycystic Kidney Diseases
91%
Tolvaptan
55%
Arginine Vasopressin
41%
Deamino Arginine Vasopressin
30%
Adenosine Monophosphate
26%
mozavaptan
21%
Disease Progression
18%
Autosomal Recessive Polycystic Kidney
18%
Fluids and Secretions
15%
Phase III Clinical Trials
14%
Kidney
12%
Vasopressins
12%
Animals
11%
Cyclic AMP
11%
Double-Blind Method
11%
Chronic Renal Insufficiency
10%
Drinking
10%
Homeostasis
8%
Hormones
8%
Clinical Studies
8%
Placebos
8%
Calcium
8%
Cell Proliferation
7%
Hypertension
7%
Phenotype
7%
Mutation
6%
Therapeutics
1%